IPIC - the obesity pill stock Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IPIC - the obesity pill stock

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: margaret foley who wrote (110)	10/1/1996 7:58:00 PM
From: margie	of 113

Believe he said one million prescriptions so far, 45 million market, so big enough market for new competitors too. Mentioned other drug that was just rejected by FDA because of increased blood pressure. Said Interneuron has had the most successful pharmaceutical launch so far, with AHP. Mentioned other drugs in pipeline. Was questionned about primary pulmonary hypertension. IPIC and all knew about this, letter was just re-explaining or re-iterating warning to physicians.. Low level of PPH 23 to 46 cases per million, get it with any appetite suppressing drug.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next